Αποτελέσματα Αναζήτησης
updated with the latest monitoring results, including details of lithium brand, formulation, dose, target levels (upper and lower), and test results (as listed in Table 1 – “monitoring guidance”).
administer and dispense lithium, identify potential lithium toxicity, monitor serum levels and adjust lithium therapy if necessary. This guideline aims to provide guidance on how to
Patients prescribed lithium must have a medication alert activated on PARIS and must be easily identifiable by search on GP clinical records (i.e. lithium added to their repeat prescription).
Acknowledge and accept secondary care team request for shared care within 4 weeks of receipt of shared care request. Set up a code and recall system to identify service users prescribed lithium. Complete entries in the patient information booklet, record book and alert card as per guidelines.
Patients prescribed lithium are monitored in accordance with best practice guidance. Prescribers check that blood tests are carried out and monitored regularly and that it is safe to issue a repeat prescription.
relevant quality outcome framework (QOF) target for lithium monitoring in the general prac-titioner contract. The 2006 guidelines from the National Institute for Health and Clinical Excellence (NICE) set out clear standards for lithium monitoring, including measure-ment of serum lithium concentrations every three months and assessment of thyroi...
19 Νοε 2010 · Lithium treatment increases the risk of clinical hypothyroidism and renal insufficiency (both acute and chronic). Thus tailoring doses for individual patients, with careful monitoring of lithium concentrations, estimated glomerular filtration rate, and thyroid stimulating hormone, is essential.
